Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.9K Hold
264
0.01% 239
2026
Q1
$14.6K Hold
264
0.01% 225
2025
Q4
$13K Hold
264
0.01% 224
2025
Q3
$11.4K Hold
264
0.01% 232
2025
Q2
$10.2K Hold
264
0.01% 233
2025
Q1
$10.2K Hold
264
0.01% 241
2024
Q4
$8.94K Buy
+264
New +$9.5K 0.01% 250

Other funds holding GSK

Asset Planning Inc's GSK Position: Q2 2026 in Review

Asset Planning Inc held its GSK (GSK) position steady in Q2 2026 at 264 shares worth $13.9K. The position accounts for 0.01% of the portfolio, ranked #239.

Asset Planning Inc first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. The position peaked at $14.6K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Asset Planning Inc held 264 shares of GSK worth $13.9K as of Q2 2026.
  • Asset Planning Inc left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.01% of Asset Planning Inc's portfolio in Q2 2026, its #239 holding.
  • Asset Planning Inc first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
  • Asset Planning Inc's GSK position peaked at $14.6K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Asset Planning Inc's 13F filing for Q2 2026, filed 27 Jul 2026.